Mediastinal Malignant Melanoma Markedly Shrinking in Response to Nivolumab

Primary malignant melanoma (MM) of the mediastinum is rare, and there is a lack of consensus regarding the preferred treatment because non-cutaneous MM demonstrates an inferior response to systemic therapy. Herein, we describe the case of a 73-year-old man with MM of the anterior mediastinum with mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakaguchi, Hiroyuki, Tanimoto, Azusa, Sato, Shigeki, Yanagimura, Naohiro, Suzuki, Chiaki, Takumi, Yohei, Nishiyama, Akihiro, Yamashita, Kaname, Takeuchi, Shinji, Ohtsubo, Koshiro, Yano, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810244/
https://www.ncbi.nlm.nih.gov/pubmed/34176837
http://dx.doi.org/10.2169/internalmedicine.7452-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810244/
https://www.ncbi.nlm.nih.gov/pubmed/34176837
http://dx.doi.org/10.2169/internalmedicine.7452-21

Ejemplares similares